Pulmonary Vascular Research Institute (PVRI)

Today marks the start of #PH Awareness Month!🎇In support of #PHDayUK, the #PVRI is committed to sharing cutting-edge research, raising awareness of PH, and addressing key challenges. Our goal is to improve diagnosis, treatment, and care for patients all around the world, and we will advocate, collaborate, and educate globally until PH is well-understood and properly resourced. https://lnkd.in/gC6qtutB Pulmonary Hypertension Association UK #PHDayUK #TogetherForPH

🎇𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝗶𝘀 𝗣𝘂𝗹𝗺𝗼𝗻𝗮𝗿𝘆 𝗛𝘆𝗽𝗲𝗿𝘁𝗲𝗻𝘀𝗶𝗼𝗻 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵! Follow PHA Europe and Pulmonary Hypertension Association throughout the month to spread #PH awareness and learn how members of the #pulmonaryhypertension community let their light shine. PHA Europe is proud to join the Pulmonary Hypertension Association in spreading #pulmonaryhypertension awareness this November. ➡Find out more: www.phaeurope.org ➡https://lnkd.in/g3QrXNH6. ‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎‎ #PHAwarenessMonth #LetYourLightShine #PHAdvocacy #pulmonaryhypertension #PAH #COPD #CTEPH #raredisease #patientempowerment #NovemberAwareness #awareness Hipertensión Pulmonar Argentina PH Belgium - Pulmonale Hypertensie vzw Hipertensión Pulmonar España ORG Pacientes Fundación Contra la Hipertensión Pulmonar Asociación Nacional de Hipertensión Pulmonar ANHP Stichting Pulmonale Hypertensie / PH Association the Netherlands PH Serbia AIPI Italian Pulmonary Hypertension Association Fundación Ayúdanos a Respirar Sociedad Latina de Hipertensión Pulmonar HAPCHI Asociacion Chilena de Hipertension Pulmonar Pulmonary Hypertension Association of South Africa

We are delighted to invite our community members to the 5th Paediatric and 2nd Adult Latin American Symposium on #PH in Sao Paulo, Brazil. Taking place 22 - 23 November 2024, the event is being organised by the leaders of the PVRI LATAM Task Force and aims to address the latest advances in diagnosis and management of adult and paediatric PH. Register➡️ https://lnkd.in/gQX8DAgB

We’re two weeks into the nomination period for the prestigious PVRI Lifetime Achievement Award 2025 and PVRI Achievement Awards 2025, and there’s still time to recognise the outstanding contributions of colleagues in the field of PH🎉 If you know someone who deserves this recognition now is the time to submit a nomination! https://lnkd.in/gqvMQZ4B The nomination period will remain open for four more weeks, closing on 25 November 2024. Thank you for helping us celebrate excellence in PH research and clinical care💜

1 week to go until the next #webinar in the 𝐇𝐲𝐩𝐨𝐱𝐢𝐚 𝐢𝐧 𝐩𝐮𝐥𝐦𝐨𝐧𝐚𝐫𝐲 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 – 𝐚𝐥𝐭𝐢𝐭𝐮𝐝𝐞 𝐚𝐧𝐝 𝐛𝐞𝐲𝐨𝐧𝐝 series 🗻 Join Andrew Murray for a presentation on ‘𝘏𝘶𝘮𝘢𝘯 𝘮𝘦𝘵𝘢𝘣𝘰𝘭𝘪𝘤 𝘳𝘦𝘴𝘱𝘰𝘯𝘴𝘦𝘴 𝘵𝘰 𝘩𝘪𝘨𝘩 𝘢𝘭𝘵𝘪𝘵𝘶𝘥𝘦 𝘩𝘺𝘱𝘰𝘹𝘪𝘢’ 5 November 2024 1PM GMT. Organised by the High Altitude Task Force & moderated by Aastha Mishra & Ulrich Silvia. Register here https://lnkd.in/gvbmTEHm

Missed it? You can now watch the replay of our #PulmonaryHypertension October Community Call here ⏯️ https://lnkd.in/g-Pq_yHG Featuring guests Eszter N. Tóth, Julien Grynblat, and Community Call hosts Katrina Barry, Tatiana V. Kudryashova & Jason Weatherald.

📢𝐇𝐨𝐭 𝐭𝐨𝐩𝐢𝐜𝐬 𝐟𝐫𝐨𝐦 𝐏𝐕𝐑𝐈 𝐆𝐨𝐃𝐞𝐞𝐩 This session will take place on Saturday, 1 February 2025. You can register for the session when you register for the #PVRI2025. Chairs: Martin Wilkins, Paul Hassoun, Werner Seeger 💜Overview of the GoDeep meta-registry, Werner Seeger 💜Risk scores beyond group 1 PH – baseline and follow-up, Athiththan Yogeswaran 💜Survival outcomes and impact of targeted PAH therapy in PoPH, Arun Jose 💜PAH-targeted therapies in group 3 PH – PDE5 inhibitor therapy associated with improved survival, Khodr Tello 💜Male survival disadvantage in PH: independent of etiology, age, disease severity, comorbidities and treatment, but race-dependent, Evan Brittain Find out more: https://lnkd.in/gfruKk4x

Our Community Call is live now! Join us for a discussion on all things PH: https://lnkd.in/gDNmCnCT

Join at 3PM BST today to discuss the latest developments in #pulmonaryhypertension https://lnkd.in/gmJyVtNe

Happening tomorrow! Join our #PulmonaryHypertension October Community Call🎙️@3PM BST with guests Eszter N. Tóth, Harm Jan Bogaard, and Julien Grynblat to discuss: 💜Deep phenotyping of unaffected carriers of pathogenic BMPR2 variants screened for pulmonary arterial hypertension 💜Pulmonary hypertension induced by right pulmonary artery occlusion: hemodynamic consequences of Bmpr2 mutation Register for free: https://lnkd.in/gmJyVtNe